This webinar will guide healthcare professionals, health IT vendors, and insurance companies to maintain information security and patient confidentiality. Also, an overview of a comparative analysis will be presented, comparing SAMHSA to the HIPAA laws relating to protected health information in general.
Regular (unencrypted) Email and Text Messaging are effective engagement and communication tools that most patients prefer and have the right to use.
HIPAA allows Providers and Business Associates on behalf of Providers to communicate with patients by unencrypted email and text message - but only when a simple 3 Step Safeguard is in place and documented.
This webinar offers guidance to build and maintain a systematic, affordable marketing effort to meet the needs of your organization within budgetary restraints, Also attendees will learn how to hire the right vendors, consultants, or develop staff internally for sustainable results.
This presentation addresses HIPAA regulations from a different perspective - from a personal perspective - from the perspective of the person in charge of moving an organization or facility toward full compliance with HIPAA.
In this webinar speaker will Discuss the regulatory guidance and agency commentary on FMV and CR, and Provide perspectives on common misunderstandings and misconceptions related to FMV and CR, also discuss Emerging best practices for documenting fair market value and Commercial Reasonableness within Fragmented Health Care Organizations.
Nearly everyone worries, over 25% of people believe they worry too much, and about 6% of people will suffer from generalized anxiety disorder (GAD).
GAD is particularly important to treat as frequently leads to depression, medical problems, and more distressing anxiety disorders like panic disorder and OCD.
In this webinar we will discuss the most recent CPT changes as well as review past CPT updates to commonly performed pain management services, Also we will discuss HCPCS codes and how to best find the medication we are looking for.
This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what is an acceptable process for communications with individuals.
In this webinar you will learn how perspective taking is a fundamental concern when treating Asperger Syndrome/High Functioning Autism, At the completion of this presentation, you will be able to view your clients diagnosed with Asperger syndrome/High Functioning Autism in a different manner, You will be able to develop strategies to help them achieve success, not only in your office, but also in any social setting.
This webinar will focus on the Stark Law's underlying technical requirements and key tenets of defensibility as they apply to physician practice acquisitions, also will discuss best practices for drafting physician employment agreements, related compensation plans and facilitating effective onboarding
This HIPAA Cyber Crime Training will discuss how to use the HIPAA rules to prevent, prepare, respond and recover from Cyber Attack , Ransomware is the easiest and safest way for cyber-criminals to extort money from the Healthcare Industry.
This session will explore the complications and requirements of each of the rules controlling student health information, HIPAA, FERPA, and 42 CFR Part 2, and provide insights into how to apply the rules in an education setting.
Recent cases and/or enforcement actions involving the Federal Civil False Claims Act (FCA) as well as the Medicare-Medicaid Anti-Kickback Statute (AKS) and/or Federal Physician Self Referral Law (Stark II) raise serious concerns regarding compliance issues with the hospital, physician practices, and other healthcare entities.
Importing FDA regulated products requires careful planning before you even start. Registration, product compliance, record and data submission must be exactly correct or your product will be detained.
Likewise, the U.S. Customs and Border Protection (CBP) must be precise or your entry is not going anywhere. Some mistakes are common, others reflect a lack of understanding of how FDA and Customs and Border Protection (CBP) operate a joint program.